Search hospitals > South Carolina > Myrtle Beach
Carolina Regional Cancer Center
Claim this profileMyrtle Beach, South Carolina 29577
Conducts research for Prostate Cancer
Conducts research for Prostate Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Small Cell Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
16 reported clinical trials
1 medical researcher
Summary
Carolina Regional Cancer Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Prostate Adenocarcinoma, Lung Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Carolina Regional Cancer Center is involved with conducting 16 clinical trials across 8 conditions. There are 1 research doctors associated with this hospital, such as Frank A. Vicini.Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Prostate Adenocarcinoma
Stage IV
Top PIs
Clinical Trials running at Carolina Regional Cancer Center
Prostate Cancer
Breast Cancer
Prostate Adenocarcinoma
Low Testosterone
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Carolina Regional Cancer Center?
Carolina Regional Cancer Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Prostate Adenocarcinoma, Lung Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Carolina Regional Cancer Center is involved with conducting 16 clinical trials across 8 conditions. There are 1 research doctors associated with this hospital, such as Frank A. Vicini.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.